相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
Laura Evans et al.
CRITICAL CARE MEDICINE (2021)
Selepressin, a novel selective V 1A receptor agonist: Effect on mesenteric flow and gastric mucosa perfusion in the endotoxemic rabbit
Stephane P. Milano et al.
PEPTIDES (2020)
Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials
Lei Zhong et al.
JOURNAL OF INTENSIVE CARE (2020)
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial
Pierre-Francois Laterre et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis
Jean-Louis Vincent et al.
CRITICAL CARE (2019)
Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial
Zi-Meng Liu et al.
INTENSIVE CARE MEDICINE (2018)
Impact of Vasoactive Medications on ICU-Acquired Weakness in Mechanically Ventilated Patients
Krysta S. Wolfe et al.
CHEST (2018)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al.
INTENSIVE CARE MEDICINE (2017)
Angiotensin II for the Treatment of Vasodilatory Shock
Ashish Khanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Outcome of patients with septic shock and high-dose vasopressor therapy
Thomas Auchet et al.
ANNALS OF INTENSIVE CARE (2017)
Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients
James A. Russell et al.
CRITICAL CARE (2017)
Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis
Roeland F. Stolk et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
A Selective V-1A Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock
Xinrong He et al.
CRITICAL CARE MEDICINE (2016)
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock The VANISH Randomized Clinical Trial
Anthony C. Gordon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Selepressin and Arginine Vasopressin Do Not Display Cardiovascular Risk in Atherosclerotic Rabbit
Olivier Boucheix et al.
PLOS ONE (2016)
What's new in vasopressin?
D. J. P. O'Callaghan et al.
INTENSIVE CARE MEDICINE (2015)
NOREPINEPHRINE: NOT TOO MUCH, TOO LONG
Claude Martin et al.
SHOCK (2015)
Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis
Tomer Avni et al.
PLOS ONE (2015)
The Selective Vasopressin Type 1a Receptor Agonist Selepressin (FE 202158) Blocks Vascular Leak in Ovine Severe Sepsis
Marc O. Maybauer et al.
CRITICAL CARE MEDICINE (2014)
Myocardial depression in sepsis: From pathogenesis to clinical manifestations and treatment
Elio Antonucci et al.
JOURNAL OF CRITICAL CARE (2014)
High versus Low Blood-Pressure Target in Patients with Septic Shock
Pierre Asfar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study
Lakhmir S. Chawla et al.
CRITICAL CARE (2014)
SELEPRESSIN, A NEW V1A RECEPTOR AGONIST: HEMODYNAMIC COMPARISON TO VASOPRESSIN IN DOGS
Olivier B. Boucheix et al.
SHOCK (2013)
Role of selective V-1a receptor agonism in ovine septic shock
Sebastian Rehberg et al.
CRITICAL CARE MEDICINE (2011)
Multicenter Study of Central Venous Oxygen Saturation (ScvO(2)) as a Predictor of Mortality in Patients With Sepsis
Jennifer V. Pope et al.
ANNALS OF EMERGENCY MEDICINE (2010)
Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside
B. Levy et al.
INTENSIVE CARE MEDICINE (2010)
Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study
Andrea Morelli et al.
CRITICAL CARE (2009)
Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial
Martin W. Duenser et al.
CRITICAL CARE (2009)
A comparison of epinephrine and norepinephrine in critically ill patients
John A. Myburgh et al.
INTENSIVE CARE MEDICINE (2008)
Vasopressin versus norepinephrine infusion in patients with septic shock
James A. Russell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock:: a randomised trial
Djillali Annane et al.
LANCET (2007)
Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions
M Leone et al.
CRITICAL CARE MEDICINE (2006)
Marked synergism between vasopressin and angiotensin II in a human isolated artery
T Hidaka et al.
CRITICAL CARE MEDICINE (2005)
Cytokine-mediated downregulation of vasopressin V1A receptors during acute endotoxemia in rats
M Bucher et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2002)
分享论文
